To make ACL reconstruction surgery less traumatic, less likely to fail and easier to recover from.
To equip surgeons with technology that enables them to deliver a less painful, stronger, less likely to fail, cosmetically superior and cost-effective ACL reconstruction result.
US Manufacturing, Low Cost, Recyclable Materials, Technology that Eliminates Guesswork, Ease of Use, Patents.
With the QuadVantage Autograft System (Instruments and Procedures) your local orthopedic surgeon can provide a superior Quadriceps ACL Reconstruction experience – one that is less traumatic, less likely to fail and easier to recover from.
QuadVantage expects that use of its Quadriceps Autograft System will make the Quadriceps procedure more cost effective than Hamstring or Cadaver alternatives and cost competitive with Patellar procedures, while delivering better results.
Dr. Paul L. Burroughs, III, a graduate of the University of North Carolina Medical School, has over 20 years of experience as a physician in Orthopedic Surgery and Sports Medicine. He specializes in arthroscopy of the knee and shoulder, advanced joint replacement techniques, knee replacements utilizing Exparel pain management and sports medicine. He also performs partial knee replacements, ACL ligament reconstruction, rotator cuff repairs, reconstruction of shoulder dislocations, and ultrasound guided injections. Dr. Burroughs is certified by the American Board of Orthopedic Surgeons and is published in the American Journal of Sports Medicine and the Journal of Arthroplasty. Dr. Burroughs serves as the Company’s Chairman and non-executive CMO (Chief Medical Officer).
As of 2-21-2023, QuadVantage terminated its Reg CF offering. However, the company continues to look for qualified investors interested in investing in the company as it prepares to commercialize its products during Q1 of 2023.
If interested in investing please contact firstname.lastname@example.org via email.